CD8A and neoplasm: Importantly, in the tumor tissues of the mice treated with CAR-shSIRPα iBMDMs, we detected increased numbers of CD3-positive and CD8-positive T cells, along with increased expression of activated caspase-3 (Fig. 7G, H).